Gray, Laura D <br/><br/>
Recombinant factor VIIa analog NN1731 (V158D/E296V/M298Q-FVIIa) enhances fibrin formation, structure and stability in lipidated hemophilic plasma.  [electronic resource] 

 -  Thrombosis research  Dec 2011 
 - 570-6 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1879-2472 
<br/><br/><label>Standard No.: </label>10.1016/j.thromres.2011.04.009  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Blood Coagulation--drug effects<br/>Factor VII--pharmacology<br/>Factor VIIa--pharmacology<br/>Fibrin--metabolism<br/>Fibrinolysis--drug effects<br/>Hemophilia A--blood<br/>Humans<br/>Mice<br/>Microscopy, Confocal<br/>Phospholipids--pharmacology<br/>Plasma--drug effects<br/>Recombinant Proteins--pharmacology<br/>Thrombin--biosynthesis